Journey Medical Corp
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $61.9M | $56.1M | $79.2M | $73.7M | $63.1M | $44.5M |
| Cost of Revenue | $20.9M | $20.9M | $22.9M | $30.8M | $32.1M | $14.6M |
| Gross Profit | $40.9M | $35.3M | $56.3M | $42.9M | $31.1M | $29.9M |
| Gross Margin | 66.2% | 62.8% | 71.1% | 58.2% | 49.2% | 67.2% |
| Operating Expenses | ||||||
| Research & Development | $480.0K | $9.9M | $7.5M | $10.9M | $2.7M | — |
| SG&A Expense | $44.4M | $40.2M | $43.9M | $59.5M | $39.8M | $22.1M |
| Operating Income | $-8.2M | $-13.7M | $-2.1M | $-27.5M | $-34.9M | $7.9M |
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | 17.6% |
| Interest Expense | $3.7M | $2.7M | $1.7M | $2.0M | $7.0M | $698.0K |
| Pretax Income | $-11.4M | $-14.6M | $-3.6M | $-29.6M | $-42.4M | $7.2M |
| Income Tax Expense | $60.0K | $61.0K | $221.0K | $63.0K | $1.6M | $1.9M |
| Net Income | $-11.4M | $-14.7M | $-3.9M | $-29.6M | $-44.0M | $5.3M |
| Net Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | 11.9% |
| EPS (Basic) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.58 |
| EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 |
| Shares Outstanding (Basic) | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 9.1M |
| Shares Outstanding (Diluted) | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 10.8M |
| Dividends Per Share | — | — | — | — | — | — |